Table 1 Clinical profile in patients with CAD and LE-PAD

CAD

70.0 ± 11.2 (Ref)

37.9% (Ref)

75.1% (Ref)

30.7% (Ref)

LE-PAD

73.5 ± 9.3 (+ 3.5 [3.4–3.6])

48.0% (1.51 [1.49–1.53])

71.6% (0.83 [0.82–0.84])

33.3% (1.13 [1.11–1.14])

ACS

69.4 ± 12.2 (Ref)

37.2% (Ref)

75.2% (Ref)

34.7% (Ref)

SA

70.7 ± 10.1 (+ 1.3 [1.3–1.3])

38.7% (1.06 [1.06–1.07])

75.1% (1.00 [0.99–1.01])

26.6% (0.68 [0.67–0.69])

CLI

74.4 ± 10.1 (+ 5.0 [4.9–5.1])

52.3% (1.85 [1.82–1.89])

65.6% (0.63 [0.62–0.64])

26.5% (0.68 [0.66–0.69])

IC

73.0 ± 8.7 (+ 3.5 [3.5–3.6])

45.2% (1.39 [1.37–1.41])

75.6% (1.02 [1.00–1.04])

37.9% (1.15 [1.13–1.17])

CAD

73.1% (Ref)

61.1% (Ref)

41.2% (Ref)

5.5% (Ref)

LE-PAD

77.6% (1.28 [1.26–1.30])

48.6% (0.60 [0.59–0.61])

57.9% (1.96 [1.94–1.99])

27.3% (6.39 [6.29–6.49])

ACS

69.8% (Ref)

58.2% (Ref)

37.9% (Ref)

4.3% (Ref)

SA

76.5% (1.40 [1.39–1.42])

64.1% (1.28 [1.27–1.29])

44.6% (1.32 [1.31–1.33])

6.8% (1.64 [1.61–1.66])

CLI

73.0% (1.17 [1.14–1.20])

38.4% (0.45 [0.44–0.46])

65.5% (3.12 [3.05–3.19])

45.5% (18.7 [18.2–19.1])

IC

80.7% (1.81 [1.77–1.85])

55.5% (0.89 [0.88–0.91])

52.7% (1.83 [1.80–1.86])

14.9% (3.91 [3.81–4.01])